The Arab Company for Drug Industries and Medical Appliances (ACDIMA) established an EGP 800 mn pharma plant to manufacture hormone meds, plant manager Samir Thabet tells Al Borsa. The company, which owns a controlling 55% stake, is targeting EGP 300 mn in sales from the plant by year’s end.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Electricity Ministry studies changing how your electricity bill gets calculated
The plan is still under study, and neither of the…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…